Libo Yan
Impact in
- Aging top 5%
- Genetics, Aging, and Longevity in Model Organisms
- Hepatology top 5%
- Hepatitis C virus research
Papers in
-
- Hepatitis C virus research 6
- Epidemiology 17
- Hepatitis B Virus Studies 12
- Liver Disease Diagnosis and Treatment 10
- Co-authors
- Yan Xu (8 shared papers)Qingchun Cai (5 shared papers)Qi Cai (1 shared paper)Hong Tang (9 shared papers)Lingyao Du (13 shared papers)Lang Bai (9 shared papers)Erjie Tian (2 shared papers)Hong Zhang (3 shared papers)
- Journals
- Scientific Reports (4 papers)The FASEB Journal (2 papers)Developmental Biology (1 paper)BMJ Open (1 paper)PLoS ONE (1 paper)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Libo Yan
49 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 85
- Aging 82
- Hepatology 129
- Epidemiology 381
- Cell Biology 152
- Cancer Research 110
Countries citing papers authored by Libo Yan
This map shows the geographic impact of Libo Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Libo Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Libo Yan more than expected).
Fields of papers citing papers by Libo Yan
This network shows the impact of papers produced by Libo Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Libo Yan. The network helps show where Libo Yan may publish in the future.
Co-authors
The 25 scholars most cited alongside Libo Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 193 | |
| 2 | 2014 | 100 | |
| 3 | 2017 | 83 | |
| 4 | 2013 | 74 | |
| 5 | 2019 | 58 | |
| 6 | 2010 | 53 | |
| 7 | 2015 | 50 | |
| 8 | 2012 | 45 | |
| 9 | 2014 | 32 | |
| 10 | 2013 | 32 | |
| 11 | 2007 | 27 | |
| 12 | 2015 | 25 | |
| 13 | 2014 | 22 | |
| 14 | 2010 | 21 | |
| 15 | 2016 | 18 | |
| 16 | 2016 | 16 | |
| 17 | 2017 | 14 | |
| 18 | 2020 | 13 | |
| 19 | 2020 | 12 | |
| 20 | 2023 | 12 |
About Libo Yan
Libo Yan is a scholar working on Hepatology, Epidemiology, Cell Biology, Aging and Cancer Research, having authored 49 papers that have together received 1.0k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (12 papers), Liver Disease Diagnosis and Treatment (10 papers), Hepatitis C virus research (6 papers), Endoplasmic Reticulum Stress and Disease (5 papers), Nanoplatforms for cancer theranostics (3 papers), Sphingolipid Metabolism and Signaling (3 papers), Genetics, Aging, and Longevity in Model Organisms (3 papers) and Cancer Research and Treatments (2 papers). The work is most often cited by research in Aging (82 citations), Hepatology (129 citations), Epidemiology (381 citations), Cell Biology (152 citations) and Cancer Research (110 citations). Libo Yan has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Yan Xu, Qingchun Cai, Qi Cai, Hong Tang, Lingyao Du, Lang Bai, Erjie Tian, Hong Zhang, Yuxia Zhang and Jinghua Han. Their work appears in journals such as Scientific Reports, The FASEB Journal, Developmental Biology, BMJ Open and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.